Evaxion Partners With Pharmaceutical Company #Afrigen Biologics to Develop Novel #mRNA Vaccine Against Gonorrhea
➡ Partnership based on a highly protective #vaccine candidate identified by Evaxion Biotech A/S’s EDENTM platform
➡ The collaboration will access mRNA technology from the World Health Organization and Medicines Patent Pool’s mRNA Vaccine Technology Transfer Hub
➡ Afrigen responsible for the development and commercialization of the resulting mRNA vaccine in LMICs and African territories
Read more:
© 2018 All rights reserved
CREATED BY JANE-EYE CREATIVE
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |